Quarterly report pursuant to Section 13 or 15(d)

Business Segment Information - Comparable Adjustments (Details)

v3.20.2
Business Segment Information - Comparable Adjustments (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 10 Months Ended 12 Months Ended
Aug. 31, 2020
Aug. 31, 2019
Aug. 31, 2020
Aug. 31, 2019
Aug. 31, 2020
Feb. 29, 2020
Cost of product sold            
Net gain (loss) on undesignated derivative contracts $ 23.3 $ (16.0) $ (29.4) $ (35.7)    
Total cost of product sold (1,044.6) (1,158.1) (2,019.7) (2,226.6)    
Selling, general, and administrative expenses            
Net gain (loss) on undesignated derivative contracts 23.3 (16.0) (29.4) (35.7)    
Total selling, general, and administrative expenses (399.1) (439.4) (752.4) (845.4)    
Impairment of assets held for sale 22.0 (27.0) (3.0) (27.0)    
Disposal Group, Not Discontinued Operations | Black Velvet Divestiture            
Selling, general, and administrative expenses            
Gain (loss) on sale of business (3.0) 0.0 (3.6) 0.0 $ 70.5 $ 74.1
Foreign currency contracts | Selling, general, and administrative expenses            
Cost of product sold            
Net gain (loss) on undesignated derivative contracts 5.9 (5.1) (20.0) (8.9)    
Selling, general, and administrative expenses            
Net gain (loss) on undesignated derivative contracts 5.9 (5.1) (20.0) (8.9)    
Comparable Adjustments            
Cost of product sold            
Strategic business development costs (0.8) (18.0) (25.1) (62.5)    
COVID-19 incremental costs (0.9) 0.0 (5.5) 0.0    
Flow through of inventory step-up (0.1) (0.8) (0.1) (1.2)    
Accelerated depreciation 0.0 (1.8) 0.0 (5.3)    
Recovery of (loss on) inventory write-down 0.0 8.6 0.0 8.6    
Total cost of product sold 28.8 (19.5) (16.5) (82.0)    
Selling, general, and administrative expenses            
Restructuring and other strategic business development costs (5.8) 0.5 (8.9) (23.1)    
COVID-19 incremental costs (0.9) 0.0 (5.5) 0.0    
Transaction, integration, and other acquisition-related costs (3.1) (3.2) (3.9) (5.5)    
Impairment of intangible assets 0.0 (11.0) 0.0 (11.0)    
Other gains (losses) (2.9) (12.3) 4.5 1.1    
Total selling, general, and administrative expenses (9.9) (26.0) (20.9) (38.5)    
Impairment of assets held for sale 22.0 (27.0) (3.0) (27.0)    
Comparable Adjustments, Operating income (loss) 40.9 (72.5) (40.4) (147.5)    
Gain on vineyard sale 0.0 0.0 8.8 0.0    
Increase in our ownership interest in Nelson’s Green Brier 0.0 11.8 0.0 11.8    
(Increase) in estimated fair value of a contingent liability associated with a prior period acquisition 0.0 (13.3) 0.0 (11.4)    
Comparable Adjustments | Selling, general, and administrative expenses            
Cost of product sold            
COVID-19 incremental costs 1.9 0.0 (4.6) 0.0    
Selling, general, and administrative expenses            
COVID-19 incremental costs 1.9 0.0 (4.6) 0.0    
Comparable Adjustments | Commodity derivative contracts            
Cost of product sold            
Net gain (loss) on undesignated derivative contracts 17.4 (10.9) (9.4) (26.8)    
Settlements of undesignated commodity derivative contracts 13.2 3.4 23.6 5.2    
Selling, general, and administrative expenses            
Net gain (loss) on undesignated derivative contracts 17.4 (10.9) (9.4) (26.8)    
Comparable Adjustments | Foreign currency contracts            
Cost of product sold            
Net gain (loss) on undesignated derivative contracts 0.0 0.0 (8.0) 0.0    
Selling, general, and administrative expenses            
Net gain (loss) on undesignated derivative contracts $ 0.0 $ 0.0 $ (8.0) $ 0.0